全文获取类型
收费全文 | 519篇 |
免费 | 32篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 12篇 |
妇产科学 | 16篇 |
基础医学 | 61篇 |
口腔科学 | 20篇 |
临床医学 | 28篇 |
内科学 | 68篇 |
皮肤病学 | 5篇 |
神经病学 | 16篇 |
特种医学 | 57篇 |
外科学 | 149篇 |
综合类 | 2篇 |
预防医学 | 32篇 |
眼科学 | 20篇 |
药学 | 46篇 |
肿瘤学 | 18篇 |
出版年
2022年 | 3篇 |
2021年 | 7篇 |
2020年 | 4篇 |
2019年 | 7篇 |
2018年 | 8篇 |
2016年 | 3篇 |
2015年 | 4篇 |
2014年 | 12篇 |
2013年 | 11篇 |
2012年 | 14篇 |
2011年 | 26篇 |
2010年 | 28篇 |
2009年 | 29篇 |
2008年 | 53篇 |
2007年 | 37篇 |
2006年 | 17篇 |
2005年 | 20篇 |
2004年 | 24篇 |
2003年 | 21篇 |
2002年 | 20篇 |
2001年 | 16篇 |
2000年 | 14篇 |
1999年 | 11篇 |
1998年 | 5篇 |
1997年 | 6篇 |
1992年 | 13篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 9篇 |
1988年 | 12篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1979年 | 8篇 |
1978年 | 3篇 |
1976年 | 5篇 |
1975年 | 4篇 |
1974年 | 7篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1968年 | 5篇 |
1966年 | 4篇 |
1960年 | 3篇 |
1959年 | 4篇 |
1936年 | 2篇 |
排序方式: 共有551条查询结果,搜索用时 46 毫秒
1.
2.
3.
B Zoll J Bal J Pohnke B Bockel U Sancken O Knobloch 《Monatsschrift für Kinderheilkunde》1992,140(3):177-182
In a former molecular segregation analysis of fra x mental retardation in 27 families at risk we had used marker gene probes with a relatively high recombination fraction. Thus, the resulting risk for a false diagnosis was comparatively high. To diminish this risk, all families were reanalyzed with the newly invented and more closely linked gene probes RN1A, VK23B, VK21C and U6.2. Using these probes as molecular markers we performed Southern hybridization experiments. The remaining diagnostic risk due to recombination events could be reduced to 2% up to 20% compared to preanalysis. The portion of informative families (91%) is in good agreement with the expected cumulative heterozygosis frequency of 93.4% for all 4 markers investigated. This high frequency and the very low remaining risk for a false diagnosis therefore enable a far more precise molecular diagnostic of the Martin-Bell-syndrome. 相似文献
4.
M Knobloch G Sch?nrich J Schenkel M Malissen B Malissen A M Schmitt-Verhulst G J H?mmerling B Arnold 《International immunology》1992,4(10):1169-1174
Activation of mature lymphocytes requires in addition to the TCR contact with the corresponding antigen the binding of the CD8 or CD4 co-receptors to MHC class I or class II proteins respectively. To investigate the contribution of the CD8-class I interaction to the elimination of autoreactive T cells during negative selection in the thymus we generated two types of transgenic mice. One set expressed a modified Kb molecule which contained a human HLA-A2 alpha 3 domain, thereby missing the binding residues for the murine CD8 molecules. The second set of mice expressed an anti-Kb specific TCR. Both lines were crossed and in the resulting double transgenic mice the development of Kb-reactive T cells was followed with an anti-clonotypic antibody. Surprisingly, efficient clonal deletion in the thymus was still observed, although the reduced CD8-class I adhesion abrogated effector functions in vivo and in vitro. These results imply that even T cells with intermediate affinity for self are negatively selected in the thymus despite the fact that they are not able to react against self antigens in the periphery. Thus a safety window is created which decreases the risk of autoaggression. 相似文献
5.
Prof. Dr. P.M. Vogt P. Kolokythas A. Niederbichler K. Knobloch K. Reimers C.Y. Choi 《Der Chirurg》2007,78(4):335-342
The success of modern burn therapy is based mainly on special burn intensive care, topical treatment, early eschar excision, and wound closure by immediate skin grafting or skin substitutes. This paper describes the current state of wound care and skin substitutes in burn therapy. 相似文献
6.
Mechanism of antimicrobial activity of essential oils 总被引:1,自引:0,他引:1
7.
8.
9.
Daikeler T Maas K Weiss B Hartmann J Knobloch A Arning M Kanz L Bokemeyer C 《Oncology reports》1997,4(3):561-564
Gemcitabine (dFdC) is a novel pyrimidine antimetabolite with documented antineoplastic activity against metastatic non-small cell lung cancer (NSCL), pancreatic carcinoma, ovarian and breast cancer. The side effects of gemcitabine are generally mild; severe infections are reported in less than Ilo of patients. In contrast, other new nucleoside analogues such as the purine antimetabolite fludarabine lead to a significant alteration of the CD4/CD8 lymphocyte ratio associated with an increased risk for opportunistic infections. This study investigates the effect of gemcitabine on different lymphocyte subsets during consecutive applications. 16 patients with solid rumours (3 non-small cell lung cancer, 3 pancreas, 3 testicular, 2 breast, ovarian germ-cell, 1 ovarian, 1 small cell lung, 1 gastric cancer, 1 carcinoma of unknown primary); 15 patients were previously treated, received at least 3 applications of gemcitabine (1,000 mg/m(2) as a 30 min infusion, at days 1, 8, 15; q 4 weeks). Lymphocytes surface antigens were analysed by standard technique flow cytometry prior to every infusion. The median number of leukocytes before therapy was 7823/mu l, with lymphocytes 875/mu l, including 68% T-cells (CD3(+)), 9% B-cells (CD19(+); CD20(+)) and 15% NK-cells (CD56(+); CD16(+); CD3(-)), the CD4/CD8 ratio was 1.7. After gemcitabine therapy the median number of leukocytes was 5136/mu l, with lymphocytes 1012/mu l, including 77% T-cells, 8% B-cells and 10% NK-cells and a CD4/CD8 ratio of 2.2. Severe complications or opportunistic infections were not seen in these 16 patients. No significant change of CD4/CD8 ratios and NK-ccll numbers was seen in our patients with solid tumours during weekly treatment with gemcitabine. A severely increased risk for opportunistic infections following treatment with the new antimetabolite gemcitabine appears unlikely. 相似文献
10.
Expression of the fibroblast growth factor 4 (FGF-4) gene is tightly regulated during mammalian development. Dysregulation of FGF-4 gene expression results in cell transformation and tumorigenesis. It is therefore pertinent to investigate the regulatory mechanisms which control expression of FGF-4. In an initial attempt to identify exogenous factors other than retinoic acid which might control FGF-4 expression, we have investigated the response of endogenous FGF-4 to serum in a number of embryonal carcinoma and embryonic stem cell lines. We have identified a human embryonal carcinoma cell line (Tera-2) in which the FGF-4 gene can be induced by serum. In Tera-2 cells made quiescent by serum deprivation, expression of the FGF-4 gene is repressed. Subsequent addition of serum reactivates FGF-LC expression and further addition of cycloheximide results in superinduction of mRNA suggesting that FGF-4 may be classified as an early response gene. It is suggested that this observation may be explained, at least in part, by the stage of differentiation of the Tera-2 cells. 相似文献